Columbia Care Introduces New Line of Formulated Cannabis Tablets, PRESS 2.0
Hard-Pressed Tablets Formulated for Morning, Afternoon and Night Now Available in Five
“A growing number of patients and customers are looking for a discreet and reliable way to consume cannabis – which is exactly what our PRESS brand offers,” said BJ Carretta, SVP of Brands,
PRESS 2.0 was created as a portable, convenient, and discreet option. All three new products feature fast-acting cannabis and special formulations designed for morning, afternoon, and night routines: Shine tablets include CBG, green tea extract, turmeric and vitamin C to fine tune your morning; Rally tablets are made with CBG, turmeric and vitamin B12 for the afternoon slump; and the Doze tablets feature CBD and magnesium to wind down your day.
For more information about PRESS and PRESS 2.0, visit www.presstablets.com.
Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10 dated
View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005781/en/